Early weight gain after diagnosis may have an impact on remission status in children with new-onset type 1 diabetes mellitus
- PMID: 37572062
- PMCID: PMC10755610
- DOI: 10.1111/1753-0407.13455
Early weight gain after diagnosis may have an impact on remission status in children with new-onset type 1 diabetes mellitus
Abstract
Background: Residual beta-cell function and improvement in insulin sensitivity by reversal of glucose toxicity are two phenomena thought to be related to partial remission (PR). Body fat mass is the major determinant of insulin sensitivity. The aim of this study is to investigate the relationship between the rate of body weight gain after diagnosis of type 1 diabetes mellitus (T1DM) and other clinical factors for the development and duration of PR.
Methods: Children (2-16 years) with new-onset T1DM (n = 99) were grouped into remitters and non-remitters by using insulin dose-adjusted glycosylated hemoglobin (HbA1c) values. Laboratory and clinical data as well as daily insulin requirement per kilogram of body weight at diagnosis and each visit were recorded, and the duration of PR was determined. Changes in body mass index standard deviation score (BMI-SDS) were calculated by the auxological data collected every 6 months.
Results: There were 47 remitters (47.5%) and 52 (52.5%) non-remitters. The mean increase in BMI-SDS at the first 6 months of diagnosis was higher in the non-remitters than in the remitters (p = 0.04). Duration of PR was negatively correlated with the change in BMI-SDS between 6 and 12 months after diagnosis. Male sex, younger age, prepubertal status, and lower HbA1c were predictors of remission, among which male sex had the highest chance by multivariate regression.
Conclusions: Early rapid weight gain after diagnosis of T1DM may play a role in the lack of remission and shorter duration of PR. Interventions to prevent early rapid weight gain can maintain the development and prolongation of remission.
背景:残余β细胞功能和通过逆转葡萄糖毒性改善胰岛素敏感性被认为是与部分缓解(PR)相关的两种现象。体脂质量是胰岛素敏感性的主要决定因素。本研究旨在调查1型糖尿病(T1DM)诊断后体重增加率与其他临床因素之间的关系,以确定PR的发生和持续时间 方法:将新发T1DM儿童(2-16岁)(n=99)根据胰岛素剂量调整后的HbA1c值分为缓解组和非缓解组。记录实验室和临床数据以及诊断时和每次随访时每千克体重的每日胰岛素需求量,确定PR持续时间。以每六个月收集的生长发育数据,计算体重指数标准差评分(BMI-SDS)的变化 结果:47名患者(47.5%)病情缓解,52名患者(52.5%)病情未缓解。诊断后前6个月,病情未缓解患者的BMI-SDS平均增加值高于病情缓解患者(p=0.04)。PR持续时间与诊断后第6个月至第12个月BMI-SDS的变化呈负相关。多元回归分析显示男性、年轻、青春期前状态和较低的HbA1c是病情缓解的预测因素,其中男性的可能性最大 结论:T1DM诊断后早期体重快速增加可能在对难以缓解和PR持续时间较短起作用。预防早期体重快速增加的干预措施可能有助于维持和延长缓解.
Keywords: 1型糖尿病; BMI; remission; type 1 diabetes; weight change; 体重变化; 缓解.
© 2023 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no potential conflict of interest.
Figures
Similar articles
-
Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study.Pediatr Diabetes. 2019 May;20(3):286-292. doi: 10.1111/pedi.12824. Epub 2019 Feb 20. Pediatr Diabetes. 2019. PMID: 30714298
-
Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis.Diabetes Nutr Metab. 2002 Aug;15(4):246-51. Diabetes Nutr Metab. 2002. PMID: 12416662
-
Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.J Pediatr Endocrinol Metab. 2021 Jul 19;34(10):1311-1317. doi: 10.1515/jpem-2021-0048. Print 2021 Oct 26. J Pediatr Endocrinol Metab. 2021. PMID: 34271601
-
Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.Front Endocrinol (Lausanne). 2022 May 3;13:884219. doi: 10.3389/fendo.2022.884219. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592786 Free PMC article. Review.
-
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus.Trends Endocrinol Metab. 2024 Feb;35(2):151-163. doi: 10.1016/j.tem.2023.10.005. Epub 2023 Nov 8. Trends Endocrinol Metab. 2024. PMID: 37949732 Review.
References
-
- Zhong T, Tang R, Gong S, Li J, Li X, Zhou Z. The remission phase in type 1 diabetes: changing epidemiology, definitions, and emerging immuno‐metabolic mechanisms. Diabetes Metab Res Rev. 2020;36(2):e3207. - PubMed
-
- Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup‐Poulsen T, Mahon J. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care. 1992;15(1):66‐74. - PubMed
-
- Niedzwiecki P, Pilacinski S, Uruska A, Adamska A, Naskret D, Zozulinska‐Ziolkiewicz D. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes. J Diabetes Complications. 2015;29(8):1105‐1111. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials